Actuate Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +32.5% | -14.0% | -44.9% | |
| – | -14.5% | +98.6% | +88.2% | |
| – | +23.6% | +0.7% | -10.6% | |
| – | – | – | – | |
| – | +169.4% | -57.1% | +8.2% | |
| – | – | – | – | |
| – | – | – | +0.0% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.